Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Accelerate Diagnosti
(NQ:
AXDX
)
1.670
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Accelerate Diagnosti
< Previous
1
2
3
4
5
Next >
AXDX Stock Earnings: Accelerate Diagnostics Beats EPS, Misses Revenue for Q2 2024
August 09, 2024
AXDX stock results show that Accelerate Diagnostics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Dead Cat Bounce: 3 Stocks to Sell Before They Plunge Again
June 13, 2024
Don't get fooled by these dead cat bounces - here are three stocks to sell before they plunge again and pull your portfolio down.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
May 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 21, 2024
Via
Benzinga
AXDX Stock Earnings: Accelerate Diagnostics Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
AXDX stock results show that Accelerate Diagnostics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Recap: Accelerate Diagnostics Q4 Earnings
March 28, 2024
Via
Benzinga
A Preview Of Accelerate Diagnostics's Earnings
March 27, 2024
Via
Benzinga
Peering Into Accelerate Diagnostics's Recent Short Interest
January 31, 2024
Via
Benzinga
Recap: Accelerate Diagnostics Q3 Earnings
November 09, 2023
Via
Benzinga
AXDX Stock Earnings: Accelerate Diagnostics Misses EPS, Misses Revenue for Q4 2023
March 28, 2024
AXDX stock results show that Accelerate Diagnostics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 28, 2024
March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Via
Benzinga
Recap: Accelerate Diagnostics Q1 Earnings
May 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 30, 2024
Via
Benzinga
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 19, 2024
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 19, 2024
Via
Benzinga
Why Accelerate Diagnostics (AXDX) Stock Is Down 38%
January 19, 2024
Accelerate Diagnostics shares are trading lower by 38% during Friday's session. The company priced an underwritten public offering of 6,860,659 units at $1.50 each.
Via
Benzinga
US Stocks Higher; Schlumberger Earnings Beat Estimates
January 19, 2024
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market opening Friday, the Dow traded up 0.18% to 37,536.76 while the NASDAQ rose...
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
Via
Benzinga
Why Accelerate Diagnostics (AXDX) Stock Hit A New 52-Week Low Today
January 16, 2024
Accelerate Diagnostics shares are trading lower by 23.2% Tuesday morning. The company announced the initiation of a proposed underwritten public offering.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 13, 2023
Via
Benzinga
Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 14, 2023
Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial...
Via
Benzinga
Why Manchester United Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket
June 13, 2023
Gainers YS Biopharma Co., Ltd. (NASDAQ: YS) shares rose 90.3% to $2.36 in pre-market trading after dropping over 7% on Monday. YS Biopharma's PIKA Rabies Vaccine recently received Phase 3 clinical...
Via
Benzinga
Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 13, 2023
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 143% to $2.77 after the company achieved its enrollment target for its adrulipase Phase 2 SPAN trial for exocrine pancreatic...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 12, 2023
Via
Benzinga
Why Guardforce AI Shares Are Trading Lower By 59%; Here Are 20 Stocks Moving Premarket
May 03, 2023
Gainers Aptorum Group Limited (NASDAQ: APM) gained 164.3% to $7.40 in pre-market trading after gaining 8% on Tuesday. Aptorum Group recently reported 2022 fiscal year-end financial results and issued...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.